A novel TanCAR T cell designed to target both IL13 Ra2 and EphA2 can effectively recognize and eliminate glioblastoma tumor cells when encountering IL13Ra2 or EphA2 alone, as well as both targets simultaneously. The gene discussed is EPHA2; the disease is neoplasm.